Anna Campain's Publications

About Anna Campain's Publications

Senior Biostatistician
  • Conjoint Lecturer, Faculty of Medicine, UNSW Sydney
  • PhD, BSc (Adv Maths)

  • Prevalence, incidence and risk factors of diabetes in Australian adults aged ≥45 years: A cohort study using linked routinely-collected data

    Journal of Clinical & Translational Endocrinology Date published:

  • Therapy Escalation Following an Elevated HbA1c in Adults Aged 45 Years and Older Living With Diabetes in Australia: A Real-World Observational Analysis

    Diabetes Care Date published:

  • Implementing cardiovascular disease preventive care guidelines in general practice: an opportunity missed

    Medical Journal of Australia Date published:

  • EXamining ouTcomEs in chroNic Disease in the 45 and Up Study (the EXTEND45 Study): Protocol for an Australian Linked Cohort Study

    JMIR Research Protocols Date published:

  • P5319Evidence-practice gaps in the screening and management of cardiovascular risk factors in the Australian General Practice population

    European Heart Journal Date published:

  • No association between sleep apnoea and macular telangiectasia type 2 and its markers of severity and progression: a case-control study and retrospective cohort study

    Clinical & Experimental Ophthalmology Date published:

  • Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema

    Cochrane Database of Systematic Reviews Date published:

  • TWO YEAR OUTCOMES OF “TREAT AND EXTEND” INTRAVITREAL THERAPY USING AFLIBERCEPT PREFERENTIALLY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

    Retina Date published:

  • Bevacizumab or Dexamethasone Implants for DME: 2-year Results (The BEVORDEX Study)

    Ophthalmology Date published:

  • Effects of switching from ranibizumab to aflibercept in eyes with exudative age-related macular degeneration

    British Journal of Ophthalmology Date published:

  • Efficacy of dexamethasone versus bevacizumab on regression of hard exudates in diabetic maculopathy: data from the BEVORDEX randomised clinical trial

    British Journal of Ophthalmology Date published:

  • Long-Term Outcomes of Treatment of Neovascular Age-Related Macular Degeneration

    Ophthalmology Date published:

  • Patient experiences in retinal trials: a cross-sectional study

    BMC Ophthalmology Date published:

  • Two-Year Outcomes of “Treat and Extend” Intravitreal Therapy for Neovascular Age-Related Macular Degeneration

    Ophthalmology Date published:

  • Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema

    Cochrane Database of Systematic Reviews Date published:

  • Time to Initial Clinician-Reported Inactivation of Neovascular Age-Related Macular Degeneration Treated Primarily with Ranibizumab

    Ophthalmology Date published: